Compound ID | 1195

Update compound information

ML302F

Class: Beta-lactamase inhibitor (metallo-beta lactamase)

Spectrum of activity: Gram-negative
Details of activity: The drug in combination with meripenem was active against carbapenem resistant enterobacteriaceae
Combined with other compounds: Meripenem
Description: Betts. J., Phee. L., Adbul Momin. M., Brem. J., Schofield. C., Wareham. D."In Vitro and in vivo Activity of ML302F a Novel Thioenolate Metallo-β-lactamase Inhibitor " Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. 2015.
Institute where first reported: Kitasato University. Japan
Year first mentioned: 2015
Highest developmental phase: Preclinical
Development status: Active
External links:
Citation: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=3798&sKey=a9c3fb9c-e914-46aa-8248-7995700b69fe&cKey=a7686216-a213-417e-8e72-5dc9242a42ab&mKey=7a574a80-eab1-4b50-b343-4695df14907e

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.